Akari Therapeutics Plc (AKTX)
6.11
+0.29
(+4.98%)
USD |
NASDAQ |
May 07, 11:47
Akari Therapeutics SG&A Expense (TTM) : 9.294M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| DBV Technologies SA | 36.08M |
| Cellectis SA | 19.83M |
| Biodexa Pharmaceuticals Plc | 6.375M |
| Mereo BioPharma Group Plc | 23.06M |
| Bicycle Therapeutics Plc | 75.75M |